Key result
Digitalis potently and specifically inhibits the transmembrane active transport of Na+ and K+ at the cellular level, a fundamental mechanism of cardiac glycoside action.
Answers are grounded in this paper and cite their sources.
Discusses the basic mechanisms of cardiac glycoside action, specifically the inhibition of transmembrane active transport of Na+ and K+.
As we enter the third century of the clinical use of digitalis, much remains to be learned about this useful but relatively toxic family of drugs. Current thinking about basic mechanisms of cardiac glycoside action at the cellular level can be traced to the observation of Schatzmann that transmembrane active transport of Na+ and K+ is potently and specifically inhibited by digitalis.1 Schatzmann used human red blood cells in his studies, and it is of interest that this fundamental finding, presented 25 years ago, has now been extended to potential clinical usefulness by the report of Loes and his colleagues . . .
No takes yet. Share an insight, caveat, or question.
Thomas W. Smith (1978) conducted an editorial in Digitalis use and toxicity. Digitalis was evaluated. Digitalis potently and specifically inhibits the transmembrane active transport of Na+ and K+ at the cellular level, a fundamental mechanism of cardiac glycoside action.
Synapse has enriched 10 related papers. Consider them for comparative context: